Blog: CV SCIENCES, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 2.02 Results of Operations and Financial Conditions

The information provided below in “Item 7.01 – Regulation FD Disclosure” of this
Current Report on Form 8-K is incorporated by reference into this Item 2.02.

Item 7.01 Regulation FD Disclosure

On November 14, 2022, CV Sciences, Inc. (the “Company”) issued a press release
regarding the Company’s financial results for its quarter ended September 30,
2022. A copy of that press release is furnished as Exhibit 99.1 hereto and
incorporated herein by reference.The press release includes non-GAAP financial
measures as defined in Regulation G. The press release also includes a
presentation of the most directly comparable financial measures calculated and
presented in accordance with accounting principles generally accepted in the
United States (GAAP), information reconciling the non-GAAP financial measures to
the GAAP financial measures and a discussion of the reasons why the Company’s
management believes that presentation of the non-GAAP financial measures
provides useful information to investors regarding the Company’s financial
condition and results of operations. The non-GAAP financial measures presented
therein should be considered in addition to, not as a substitute for, or
superior to, financial measures calculated and presented in accordance with

Exhibit 99.1 contains forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve risks,
uncertainties and assumptions that are difficult to predict. Forward-looking
statements are based upon assumptions as to future events that may not prove to
be accurate. Actual outcomes and results may differ materially from what is
expressed in these forward-looking statements.

The information set forth under Item 7.01 of this Current Report on Form 8-K
(“Current Report”), including Exhibit 99.1 attached hereto, is being furnished
and shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of such section. The information in Item 7.01 of this Current
Report, including Exhibit 99.1, shall not be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the Exchange Act,
regardless of any incorporation by reference language in any such filing, except
as expressly set forth by specific reference in such a filing. This Current
Report will not be deemed an admission as to the materiality of any information
in this Current Report that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1   Press Release of CV Sciences, Inc. dated     November     1    4    ,



Ā© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s